What You Should Know:
– SoundHealth, a medical technology company focused on harnessing AI for better health outcomes, has launched SONU, the world’s first FDA-cleared AI-powered wearable for treating moderate to severe nasal congestion.
– The FDA De Novo classification paves the way for SONU’s safe and effective use. SoundHealth also secured $7M in seed funding to support marketing and regulatory approval for treating pediatric congestion and insomnia.
A New Option for Patients and Doctors
SONU provides a drug-free solution for adults suffering from allergies or non-allergic rhinitis. This innovative device offers relief for those seeking alternatives to medications with potential side effects. SONU utilizes acoustic resonance therapy, delivering personalized relief through gentle vibrations. Similar to humming, these vibrations may reduce congestion by influencing nasal mucosa and potentially boosting nitric oxide activity, leading to a decongestant and anti-inflammatory effect.
Scientific Backing and Medical Expertise
Clinical trials sponsored by SoundHealth have shown promising results, with a published research paper available for further exploration. Additionally, Dr. Peter Hwang, Founder and Head of Research at SoundHealth, participated in a panel discussion at the American Rhinologic Society’s Summer Sinus Symposium, showcasing the science behind acoustic resonance therapy.
Personalized Treatment with AI
SONU’s user-friendly app leverages AI to personalize treatment. Using a smartphone scan, the app creates a digital map of the user’s sinuses and calculates optimal frequencies for maximum relief.
Convenient and Effective Relief
For $299, patients simply wear the comfortable SONU band for 15 minutes, twice a day, while engaging in daily activities. The gentle vibrations, almost imperceptible, stimulate nasal nerves and may promote:
- Vasoconstriction: Reduced swelling and opened nasal passages
- Sonication: Thinning of mucus buildup
- Mucociliary clearance: Drainage of healthy mucus
“We are delighted to announce the close of our seed-round investment — the proceeds of which will be used for product launch and advancing our pipeline of indications for the SONU device. Our groundbreaking technology provides the first FDA authorized, non-pharmaceutical medical device treatment option for nasal congestion due to allergic and non-allergic rhinitis. SoundHealth’s mission is to provide personalized, intelligent wearables to help people breathe and sleep better!” said Dr. Paramesh Gopi, founder and CEO, SoundHealth.
